Nadia Younis and Dima Chebat

consultant

Nadia is an accomplished public affairs and regulatory consultant offering a unique perspective in pharma and healthcare having extensively worked for more than 30 years in both the industry and at /with the regulatory government authorities. Nadia is recognized in her field as a Regulator or as Pharma Expert for her role in the evolution and shaping the GCC-UAE regulatory frameworks and guidelines for pharma, medical devices, and clinical research in the GCC. Nadia had served at leading multinational pharma companies, where she took a leadership role and acted as a member of their ME regional leadership teams (ex; Pfizer (2011-2017), AstraZeneca (Sep 2017-May 2018)). Later, as a consultant for multinational Pharma (Jan 2019-to date) such as NewBridge pharmaceuticals, Eisai, UCB, Takeda, Abbott, Alnylam, Inibsa, Eurofarma and others, Nadia’s expertise was deployed to handle sophisticated regulatory issues with a focus on KSA, UAE, Pakistan and Algeria. Nadia’s consistent purpose is to raise awareness among authorities and companies on the importance of strengthening the regulatory system for the advancement of the country and its ECO system. Dr. Nadia is a UAE national, from Abu Dhabi, born and educated in Jordan, she is equipped with a Bachelor’s degree in Pharmacy from Jordan University (88), a Masters’ degree in Healthcare Management from Zayed University (2008) and a Master’s degree in Public Health (MPH) from John Hopkins University, School of Public Health in Baltimore, USA, (2011), where she has also completed her advanced studies for the Dr PH program (2015).